Schareck WD - Search Results

1

Risk evaluation in the use of kidneys from elder organ donors for transplantation.

Schareck WD, Hopt UT, Gaertner HV, Buesing M, Koeveker G, Smit H. Schareck WD, et al. Transplant Proc. 1990 Apr;22(2):371-2. Transplant Proc. 1990. PMID: 2326920 No abstract available.

2

Ultrastructural changes of human pancreatic allografts after cold ischemia and reperfusion.

Büsing M, Hopt UT, Schareck WD, Quacken M, Morgenroth K. Büsing M, et al. Among authors: schareck wd. Transplant Proc. 1990 Apr;22(2):612-3. Transplant Proc. 1990. PMID: 2326999 No abstract available.

3

Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.

Büsing M, Hölzer H, Schareck WD, Mellert J, Greger B, Hopt UT, Lauchart W. Büsing M, et al. Among authors: schareck wd. Transplant Proc. 1989 Feb;21(1 Pt 2):1601-3. Transplant Proc. 1989. PMID: 2652521 Clinical Trial. No abstract available.

4

Antirejection treatment in kidney transplantation--is there a proved rationale for the general use of monoclonal antibodies?

Reis HJ, Hopt UT, Greger B, Schareck WD, Bockhorn H. Reis HJ, et al. Among authors: schareck wd. Transplant Proc. 1987 Oct;19(5):3565-9. Transplant Proc. 1987. PMID: 2823424 No abstract available.

5

Immunohistochemical findings, idiotypic inhibition and clinical outcome in patients developing donor-specific antibodies after kidney transplantation.

Greger B, Pressler H, Hopt UT, Schareck WD, Müller GH, Reis HJ, Bockhorn H. Greger B, et al. Among authors: schareck wd. Transplant Proc. 1987 Oct;19(5):4286-8. Transplant Proc. 1987. PMID: 3314030 No abstract available.

6

Quality of life after combined pancreas-/kidney transplantation.

Schareck WD, Hopt UT, Geisler F, Pfeffer F, Becker HD. Schareck WD, et al. Transplant Proc. 1994 Apr;26(2):518-9. Transplant Proc. 1994. PMID: 8171533 No abstract available.

7

Induction and mechanisms of unresponsiveness in a rat renal allograft model after recipient pretreatment with specific antigen and cyclosporin and donor pretreatment with irradiation and cyclophosphamide.

Müller GH, Greger B, Schareck W, Hopt UT, Lauchart W. Müller GH, et al. Transplant Proc. 1989 Feb;21(1 Pt 1):385-7. Transplant Proc. 1989. PMID: 2650155 No abstract available.

8

Effect of anastomosis time and intraoperative organ cooling on primary function in renal transplantation.

Müller GH, Höhn U, Greger B, Schareck W, Hopt UT, Lauchart W. Müller GH, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1239. Transplant Proc. 1989. PMID: 2652407 No abstract available.

9

Suppression of the immune response in rejected sponge matrix allografts.

Thiede K, Hopt UT, Wolken D, Schareck W, Müller GH, Bockhorn H. Thiede K, et al. Transplant Proc. 1987 Feb;19(1 Pt 1):356-8. Transplant Proc. 1987. PMID: 3274785 No abstract available.

10

Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation.

Hopt UT, Pfeffer F, Schareck W, Büsing M, Ming C. Hopt UT, et al. Transplant Proc. 1994 Apr;26(2):434-5. Transplant Proc. 1994. PMID: 8171489 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters